Mark Eisner
Director; EVP and Chief Medical Officer · 3 filings · Latest: Feb 24, 2026
Vir Biotechnology, Inc.
Zura Bio Ltd
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VIR | Eisner Mark | — | Apr 30, 2026 | Proposed Sale | $10.30 | 88,958 | $916.3K | — | |
VIR | Mark Eisner | EVP and Chief Medical Officer | Feb 25, 2026 | Sale | $9.82 | 1,889 | $18.5K | 154,024 | |
VIR | Mark Eisner | EVP and Chief Medical Officer | Feb 24, 2026 | Sale | $9.53 | 1,616 | $15.4K | 155,913 | |
VIR | Eisner Mark | — | Feb 25, 2026 | Proposed Sale | $9.82 | 1,889 | $18.5K | — | |
VIR | Mark Eisner | EVP and Chief Medical Officer | Feb 23, 2026 | Sale | $7.45 | 2,089 | $15.6K | 157,529 | |
VIR | Eisner Mark | — | Feb 24, 2026 | Proposed Sale | $9.53 | 1,616 | $15.4K | — | |
VIR | Eisner Mark | — | Feb 23, 2026 | Proposed Sale | $7.45 | 2,089 | $15.6K | — | |
VIR | MARK EISNER | — | Jul 17, 2025 | Proposed Sale | $5.41 | 3,586 | $19.4K | — | |
VIR | Mark Eisner | — | Jul 15, 2025 | Proposed Sale | $5.47 | 6,796 | $37.2K | — |